Danaher Corporation (DHR)vsLaboratory Corporation of America Holdings (LH)
DHR
Danaher Corporation
$196.22
-0.16%
HEALTHCARE · Cap: $125.93B
LH
Laboratory Corporation of America Holdings
$307.15
-2.25%
HEALTHCARE · Cap: $23.24B
Smart Verdict
WallStSmart Research — data-driven comparison
Danaher Corporation generates 78% more annual revenue ($25.11B vs $14.14B). DHR leads profitability with a 16.0% profit margin vs 6.7%. DHR appears more attractively valued with a PEG of 1.15. LH earns a higher WallStSmart Score of 67/100 (B-).
DHR
Strong Buy66
out of 100
Grade: B-
LH
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-66.7%
Fair Value
$117.88
Current Price
$196.22
$78.34 premium
Margin of Safety
-38.6%
Fair Value
$209.18
Current Price
$307.15
$97.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 59.7% YoY
Large-cap with strong market position
Reasonable price relative to book value
Generating 1.3B in free cash flow
Reasonable price relative to book value
Earnings expanding 32.9% YoY
Areas to Watch
Premium valuation, high expectations priced in
ROE of 7.6% — below average capital efficiency
Moderate valuation
6.7% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : DHR
The strongest argument for DHR centers on EPS Growth, Market Cap, Price/Book. Profitability is solid with margins at 16.0% and operating margin at 18.0%. PEG of 1.15 suggests the stock is reasonably priced for its growth.
Bull Case : LH
The strongest argument for LH centers on Price/Book, EPS Growth. PEG of 1.20 suggests the stock is reasonably priced for its growth.
Bear Case : DHR
The primary concerns for DHR are P/E Ratio, Return on Equity.
Bear Case : LH
The primary concerns for LH are P/E Ratio, Profit Margin.
Key Dynamics to Monitor
DHR profiles as a mature stock while LH is a value play — different risk/reward profiles.
LH carries more volatility with a beta of 0.86 — expect wider price swings.
LH is growing revenue faster at 5.8% — sustainability is the question.
DHR generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
LH scores higher overall (67/100 vs 66/100). Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Danaher Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Laboratory Corporation of America Holdings
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories.
Visit Website →Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?